Oculopharyngeal Muscular Dystrophy: Recent Advances in the Understanding of the Molecular Pathogenic Mechanisms and Treatment Strategies.
From: Center for the Study of Brain Diseases, CHUM Research Center-Notre Dame Hospital, J.A. de Sève Pavillion, Room Y-3633, 1560, Sherbrooke Street East, Montreal, QC, Canada H2L 4M1.
Biochimica et biophysica acta
- Publish Date: Feb 2007
- ISSN: 0006-3002
- Volume: 1772
- Issue: 2
- Pages: 173-85
- Medium: Print
- Language: English
- Citation (JAMA): Abu-Baker Aida, Rouleau Guy A, et al. Oculopharyngeal Muscular Dystrophy: Recent Advances in the Understanding of the Molecular Pathogenic Mechanisms and Treatment Strategies.. Biochim. Biophys. Acta Feb 2007;1772:173-85
Abstract
Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disorder characterized by progressive eyelid drooping, swallowing difficulties and proximal limb weakness. OPMD is caused by a small expansion of a short polyalanine tract in the poly (A) binding protein nuclear 1 protein (PABPN1). The mechanism by which the polyalanine expansion mutation in PABPN1 causes disease is unclear. PABPN1 is a nuclear multi-functional protein which is involved in pre-mRNA polyadenylation, transcription regulation, and mRNA nucleocytoplasmic transport. The distinct pathological hallmark of OPMD is the presence of filamentous intranuclear inclusions (INIs) in patient’s skeletal muscle cells. The exact relationship between mutant PABPN1 intranuclear aggregates and pathology is not clear. OPMD is a unique disease sharing common pathogenic features with other polyalanine disorders, as well as with polyglutamine and dystrophic disorders. This chapter aims to review the rapidly growing body of knowledge concerning OPMD. First, we outline the background of OPMD. Second, we compare OPMD with other trinucleotide repeat disorders. Third, we discuss the recent advances in the understanding of the molecular mechanisms underlying OPMD pathogenesis. Finally, we review recent therapeutic strategies for OPMD.
Mesh Headings (Keywords): Animals, Humans, Muscular Dystrophy, Oculopharyngeal
Check for Full Text / PubMed Unique Identifier (PMID): 17110089
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.